The Priority Review

Clinical trials Brief

AstraZeneca posts results of L-MOCA olaparib maintenance trial

The company posted first results for its Phase 3 L-MOCA study, enrolling 225 participants who received olaparib 300mg tablets as maintenance therapy after platinum-based chemotherapy. The trial, which began on May 29, 2018, completed primary data collection on January 27, 2025.

Primary source

ClinicalTrials.gov results record, November 16, 2026

Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Read the source: Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy clinicaltrials.gov

Machine-summarized from the source above; not independently reported. How we use automation